Intensity Therapeutics Inc (INTS)

May 22, 2026

Intensity Therapeutics Inc. (INTS) upgraded to buy: Here's what you should know - MSN

May 22, 2026

May 22, 2026

INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill

May 22, 2026

May 20, 2026

Benchmark reiterates Intensity Therapeutics stock rating on clinical progress By Investing.com - Investing.com South Africa

May 20, 2026

May 20, 2026

Benchmark reiterates Intensity Therapeutics stock rating on clinical progress - Investing.com India

May 20, 2026

May 20, 2026

INTS News | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill

May 20, 2026

May 18, 2026

INTS Technical Analysis | Trend, Signals & Chart Patterns | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill

May 18, 2026

May 14, 2026

Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN

May 14, 2026

May 14, 2026

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award - ChartMill

May 14, 2026

May 13, 2026

Intensity Therapeutics Inc. (INTS) could find a support soon, here's why you should buy the stock now - MSN

May 13, 2026

May 11, 2026

How Intensity (INTS) maintains its competitive edge | Q4 2025: Earnings UnderperformMomentum Pick - Newser

May 11, 2026

May 09, 2026

A. G. P. Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 09, 2026

May 08, 2026

How Intensity (INTS) talent strategy drives results | Q1 2026: Profit Exceeds ViewsEarnings Acceleration Picks - Newser

May 08, 2026

May 07, 2026

Intensity Therapeutics (NASDAQ:INTS) Q1 2026 Results Show EPS Beat Despite No Revenue - ChartMill

May 07, 2026

May 07, 2026

8-K: Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updatemoomoo - Moomoo

May 07, 2026

May 07, 2026

Trial updates frame Intensity Therapeutics (NASDAQ: INTS) Q1 2026 loss - Stock Titan

May 07, 2026

May 07, 2026

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Barchart.com

May 07, 2026

May 07, 2026

Intensity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

INTENSITY THERAPEUTICS ($INTS) Releases Q1 2026 Earnings - Quiver Quantitative

May 07, 2026

May 06, 2026

INTS Q1'26 Earnings: EPS estimate is (1.08) USD - TradingView

May 06, 2026

May 05, 2026

Why Intensity (INTS) ability to execute stands out (Slow Grind) 2026-05-05Top Analyst Picks - newser.com

May 05, 2026

May 03, 2026

Intensity Therapeutics (INTS) price target decreased by 12.76% to 49.98 - MSN

May 03, 2026

May 01, 2026

Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance Singapore

May 01, 2026

Apr 30, 2026

Intensity Therapeutics (INTS) proxy adds equity plan shares, sets 2026 virtual vote - Stock Titan

Apr 30, 2026

Apr 30, 2026

[ARS] INTENSITY THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 30, 2026

Apr 27, 2026

Intensity Therapeutics (INTS) price target decreased by 11.32% to 57.29 - MSN

Apr 27, 2026

Apr 27, 2026

Why Is Retail Going Gaga Over INTS Stocks Today? - MSN

Apr 27, 2026

Apr 25, 2026

Intensity Therapeutics announces pricing of $4M registered direct offering of common stock - MSN

Apr 25, 2026

Apr 24, 2026

Intensity Therapeutics (INTS) Institutional Ownership 2026 $INTS - MarketBeat

Apr 24, 2026

Apr 23, 2026

Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update - Aktiellt

Apr 23, 2026

Apr 17, 2026

Why Did INTS Stock Plummet 25% Today? - Dailyhunt

Apr 17, 2026

Apr 16, 2026

Intensity Therapeutics Inc. (INTS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Apr 16, 2026

Apr 15, 2026

Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation - ADVFN

Apr 15, 2026

Apr 15, 2026

Intensity (INTS) Stock: Market Pricing (Drifts Lower) 2026-04-15Chart Pattern Alerts - Newser

Apr 15, 2026

Apr 13, 2026

Support Test: Can Intensity Therapeutics Inc disrupt its industryGap Down & Long-Term Safe Investment Ideas - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Intratumoral Cancer Therapies Market: Expanding Revenue Landscape to 2034 – DelveInsight | Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharma, Checkmate Pharma, Replimune - Barchart

Apr 10, 2026

Apr 10, 2026

Intratumoral Cancer Therapies Market: Expanding Revenue - openPR.com

Apr 10, 2026

Apr 10, 2026

Update Report: Is Intensity Therapeutics Inc likely to announce a buybackQuarterly Investment Review & Comprehensive Market Scan Reports - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Aug Technicals: Does Intensity Therapeutics Inc have a competitive edge2026 Trends & Expert Approved Trade Ideas - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Aug Fed Impact: Can Intensity Therapeutics Inc benefit from deglobalization2026 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

RSI Check: What are Intensity Therapeutics Incs recent SEC filings showingPortfolio Update Summary & Weekly Sector Rotation Insights - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Is Intensity (INTS) Stock Good for Passive Investors | Price at $5.49, Down 2.92%Open Stock Picks - Newser

Apr 06, 2026

Mar 31, 2026

Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), IQVIA Holdings (IQV) and Xenon (XENE) - The Globe and Mail

Mar 31, 2026